Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.

MLA

Arslan, Shukaib, et al. “Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.” Current Treatment Options in Oncology, vol. 22, no. 7, July 2021, pp. 1–17. EBSCOhost, https://doi.org/10.1007/s11864-021-00860-1.

APA

Arslan, S., Pullarkat, V., & Aldoss, I. (2021). Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission. Current Treatment Options in Oncology, 22(7), 1–17. https://doi.org/10.1007/s11864-021-00860-1

Chicago

Arslan, Shukaib, Vinod Pullarkat, and Ibrahim Aldoss. 2021. “Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.” Current Treatment Options in Oncology 22 (7): 1–17. doi:10.1007/s11864-021-00860-1.